Money Control Place
  • Politics
  • Business
  • Stocks
  • Investing
  • Politics
  • Business
  • Stocks
  • Investing

Money Control Place

Business

CVS Health to no longer sell decongestants with phenylephrine

by October 22, 2023
October 22, 2023
CVS Health to no longer sell decongestants with phenylephrine

U.S. pharmacy chain CVS Health said on Thursday it is pulling some of the most common decongestants with phenylephrine as the only active ingredient from its shelves and will no longer sell them.

The move comes after a panel of advisers to U.S. health regulators raised doubts over the efficacy of the ingredient.

Last month, the panel refused to back the effectiveness of oral over-the-counter medicines made with phenylephrine, adding that no more trials were required to prove otherwise.

CVS said “other oral cough and cold products will continue to be offered to meet consumer needs.”

Phenylephrine was substituted for pseudoephedrine in many non-prescription cold and allergy medicines after the latter was restricted amid reports of abuse.

Phenylephrine is a major component used in some of popular products like Benadryl, Sudafed, GSK’s Advil and Kenvue’s Tylenol.

This post appeared first on NBC NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Abortion bans and anti-LGBTQ laws are complicating business travel
next post
China adopted ‘more dangerous’ tactics in 2022 as ‘only competitor’ to US, Pentagon warns in new report

Related Posts

Dow slips for first losing day in nine...

May 15, 2024

The IRS’s new, free ‘Direct File’ service for...

February 28, 2024

Home Depot earnings beat Wall Street estimates as...

February 27, 2025

Long-predicted consumer pullback finally hits restaurants like Starbucks,...

May 2, 2024

Cracker Barrel shares plummet after pushback on new...

August 23, 2025

Dick’s Sporting Goods stands by full-year guidance —...

May 29, 2025

Starbucks unveils plan to add 17,000 locations by...

November 4, 2023

Doubt grows over Buy Buy Baby sale process...

June 30, 2023

Disney drops all but free speech claim in...

September 8, 2023

Bed Bath & Beyond relaunches with first store...

August 13, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    • 10 Silver ETFs for Every Investing Style in 2025

    • Humanoid Robotics: Key Trends to Watch and Investment Insights

    • Why SQM Says Social Dialogue is Key to Sustainable Lithium

    • Group Eleven Drills New Mineralized Zone South of Main Discovery Trend at Ballywire, Returning 7.3m of 5.2% Zn+Pb, 10 g/t Ag , Incl. 3.8m of 7.3% Zn+Pb, 14 g/t Ag

    • Blackrock Silver Announces Final Assays from Eastern Expansion Drill Program at Tonopah West

    Categories

    • Business (1,418)
    • Investing (3,224)
    • Politics (3,699)
    • Stocks (1,868)
    • Uncategorized (20)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: MoneyControlPlace.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 moneycontrolplace.com | All Rights Reserved